Blueblood Ventures Limited

Equities

BVL6

INE562S01013

Investment Banking & Brokerage Services

Market Closed - Bombay S.E. Other stock markets 06:00:56 2023-05-29 EDT			5-day change	1st Jan Change
11.07 ^INR	+4.93%		-.--%	-.--%

05-27	Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
05-18	Pushpendra Surana Resigns as Director of Blueblood Ventures Limited	CI

BlueBlood Ventures Limited cancelled the acquisition of 99.99% stake in Fullerton Securities & Wealth Advisors Limited from Angelica Investments Pte. Ltd.

December 15, 2018

BlueBlood Ventures Limited (BSE:539637) entered into an agreement to acquire 99.99% stake in Fullerton Securities & Wealth Advisors Limited from Angelica Investments Pte. Ltd. for approximately INR 230 million on December 16, 2017. The transaction is expected to complete by January 31, 2018. BlueBlood Ventures Limited (BSE:539637) cancelled the acquisition of 99.99% stake in Fullerton Securities & Wealth Advisors Limited from Angelica Investments Pte. Ltd. on December 16, 2018.

Latest news about Blueblood Ventures Limited

Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-27	CI
Pushpendra Surana Resigns as Director of Blueblood Ventures Limited	05-18	CI
Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-14	CI
BlueBlood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-09-11	CI
BlueBlood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-14	CI
BlueBlood Ventures Limited Approves Amit Kumar Lal Not Standing for Re-Election	22-09-30	CI
BlueBlood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-30	CI
BlueBlood Ventures Limited Announces Appointment of Jatin Bhatia as Company Secretary and Compliance Officer	22-02-24	CI
BlueBlood Ventures Limited Announces Resignation of Palak Chopra as Company Secretary and Compliance Officer	22-02-24	CI
BlueBlood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-13	CI
Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2021	21-06-28	CI
BlueBlood Ventures Limited Announces Resignation of Raman Rastogi as Company Secretary & Compliance Officer	21-06-17	CI
BlueBlood Ventures Limited Announces Resignation of Manjeet Pugalia as Independent Director	21-01-19	CI
Blueblood Ventures Limited Announces Resignation of Neha Bansal as Company Secretary and Compliance Officer	20-12-07	CI
Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2020	20-11-12	CI
BlueBlood Ventures Limited Announces Board Changes	20-09-04	CI
Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2020	20-07-31	CI
Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2019	19-11-29	CI
BlueBlood Ventures Limited Announces Regularization of Appointment of Narsimha Kavadi as an Independent Non-Executive Director	19-09-04	CI
Blueblood Ventures Limited Announces Audited Standalone Earnings Results for the Half Year and Full Year Ended March 31, 2019	19-05-29	CI
BlueBlood Ventures Limited Appoints Narsimha Kavadi as Independent Director	19-05-29	CI
600,216 Equity Shares of BlueBlood Ventures Limited are subject to a Lock-Up Agreement Ending on 3-FEB-2019.	19-02-02	CI
BlueBlood Ventures Limited cancelled the acquisition of 99.99% stake in Fullerton Securities & Wealth Advisors Limited from Angelica Investments Pte. Ltd.	18-12-15	CI
BlueBlood Ventures Limited Announces Standalone Unaudited Earnings Result for the Half Year Ended September 30, 2018	18-11-14	CI
Blueblood Ventures Limited Appoints Suresh Bohra as Chief Financial Officer	18-09-29	CI

Chart Blueblood Ventures Limited

Duration

Period

More charts

Company Profile

Blueblood Ventures Limited is an India-based company that is engaged in the business of security and commodity contracts brokerage, and management consultancy activities. The Company is involved in the business of equity investment and trading in equity, derivatives, currencies, venture capital funding, commodities, futures and options, as well as other financial products. The Company is also engaged in investment in real estate segment.

Sector

Investment Banking & Brokerage Services

Calendar

2024-11-12 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Banking & Brokerage Services

	1st Jan change	Capi.
BLUEBLOOD VENTURES LIMITED	-.--%	399K
MORGAN STANLEY	+4.92%	158B
THE GOLDMAN SACHS GROUP, INC.	+18.34%	153B
CHARLES SCHWAB	+6.51%	131B
CITIGROUP INC.	+21.13%	118B
CITIC SECURITIES COMPANY LIMITED	-8.59%	35.36B
RAYMOND JAMES FINANCIAL, INC.	+10.10%	25.26B
LPL FINANCIAL HOLDINGS INC.	+25.74%	20.87B
CSC FINANCIAL CO., LTD.	-9.42%	19.97B
NOMURA HOLDINGS, INC.	+49.05%	17.3B

Other Investment Banking & Brokerage Services